Fig. 1From: Safety and efficacy of prostatic artery embolization in patients with hematuria due to benign prostate hyperplasiaFlowchart of study population: prostatic artery embolization for patients with BPH, patients assessed for study (n = 125), excluded patients (n = 15), baseline evaluation (n = 110), follow-up after 3 months (n = 110), and follow-up after 6 months (n = 110)Back to article page